Research Article

IL1RN and KRT13 Expression in Bladder Cancer: Association with Pathologic Characteristics and Smoking Status

Table 2

Correlations between KRT13 and IL1RN expression and tumor characteristics in UCB tissue samples compared with controls.

CK13Group 1
( )
Group 2
( )
Group 3
( )
Group 4
( )
Groups 2–4
( )

− (≤10%)4 (28,6%)27 (60,0%)17 (53,1%)19 (59,4%)63 (57,8%)
+4 (28,6%)9 (20,0%)9 (28,1%)9 (28,1%)27 (24,8%)
++1 (7,1%)5 (11,1%)3 (9,4%)1 (3,1%)9 (8,3%)
+++5 (35,8%)4 (8,9%)3 (9,4%)3 (9,4%)10 (9,2%)

valueReference0.0190.0450.0150.007

IL1RN

− (≤10%)0 (0,0%)10 (22,2%)8 (25,0%)9 (28,1%)27 (24,8%)
+0 (0,0%)5 (11,1%)4 (12,5%)5 (15,6%)14 (12,8%)
++4 (28,6%)9 (20,0%)7 (21,9%)7 (21,9%)23 (21,1%)
+++10 (71,4%)21 (46,7%)13 (40,6%)11 (34,4%)45 (41,3%)

valueReference0.0200.0100.0030.008

Group 1 = benign tissue; group 2 = low grade tumors; group 3 = high grade UCB (non-muscle-invasive); group 4 = muscle-invasive UCB.